USA - NYSE:USNA - US90328M1071 - Common Stock
The current stock price of USNA is 19.13 USD. In the past month the price decreased by -5.58%. In the past year, price decreased by -52.47%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 52.23 | 31.62B | ||
| KVUE | KENVUE INC | 15.78 | 32.39B | ||
| ELF | ELF BEAUTY INC | 23.86 | 4.18B | ||
| BRBR | BELLRING BRANDS INC | 13.49 | 3.69B | ||
| COTY | COTY INC-CL A | 19.74 | 3.28B | ||
| IPAR | INTERPARFUMS INC | 16.68 | 2.81B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.26 | 870.20M | ||
| OLPX | OLAPLEX HOLDINGS INC | 18.33 | 733.79M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 6.61 | 451.44M | ||
| HNST | HONEST CO INC/THE | 53.3 | 296.53M | ||
| NATR | NATURES SUNSHINE PRODS INC | 19.06 | 316.11M | ||
| UPXI | UPEXI INC | N/A | 194.63M |
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,700 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
USANA HEALTH SCIENCES INC
3838 West Parkway Blvd.
Salt Lake City UTAH 84120 US
CEO: Kevin G. Guest
Employees: 1700
Phone: 18019547100
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,700 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
The current stock price of USNA is 19.13 USD. The price decreased by -0.16% in the last trading session.
USNA does not pay a dividend.
USNA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The Revenue of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 8.22% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
USANA HEALTH SCIENCES INC (USNA) has a market capitalization of 349.51M USD. This makes USNA a Small Cap stock.
USANA HEALTH SCIENCES INC (USNA) will report earnings on 2026-02-23, after the market close.
ChartMill assigns a fundamental rating of 5 / 10 to USNA. While USNA has a great health rating, its profitability is only average at the moment.
Over the last trailing twelve months USNA reported a non-GAAP Earnings per Share(EPS) of 1.96. The EPS decreased by -30.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.79% | ||
| ROA | 4.64% | ||
| ROE | 6.42% | ||
| Debt/Equity | 0 |
6 analysts have analysed USNA and the average price target is 39.78 USD. This implies a price increase of 107.95% is expected in the next year compared to the current price of 19.13.
For the next year, analysts expect an EPS growth of -33.31% and a revenue growth 8.22% for USNA